Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Total revenue $ 38,697,000 $ 18,845,000
Operating expenses:    
Research and development 84,665,000 92,965,000
General and administrative 34,106,000 26,722,000
Total operating expenses 118,771,000 119,687,000
Loss from operations 80,074,000 100,842,000
Interest and other income, net 434,000 1,028,000
Interest and other expense, net (3,369,000) (1,705,000)
Loss on extinguishment of debt 0 (1,237,000)
Loss on disposal of assets 0 (2,155,000)
Loss before provision for income taxes 83,009,000 104,911,000
Provision for income taxes 0 5,000.0
Net loss 83,009,000 104,916,000
Net loss attributable to common shareholders $ 83,009,000 $ 104,916,000
Net loss per share attributable to common shareholders:    
Basic and diluted $ 1.50 $ 2.20
Weighted average number of shares used in net loss per share calculations:    
Basic and diluted 55,297,798 47,603,261
Research And Development Revenue, Related Party    
Total revenue $ 13,136,000 $ 6,567,000
Research And Development Revenue, Other    
Total revenue 25,561,000 9,068,000
Grant    
Total revenue $ 0 $ 3,210,000